Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluate the Safety of a Vero Cell - Derived Inactivated Japanese Encephalitis Vaccine (JECEVAX) Produced by The Company for Vaccine and Biological Production No.1 in Vietnamese Children Aged 9-24 Months

NCT03204227 is registered in ClinicalTrials.gov with National Institute of Hygiene and Epidemiology, Vietnam as lead sponsor.

NCT NCT03204227
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03204227 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluate the Safety of a Vero Cell - Derived Inactivated Japanese Encephalitis Vaccine (JECEVAX) Produced by The Company for Vaccine and Biological Production No.1 in Vietnamese Children Aged 9-24 Months
Lead sponsor
National Institute of Hygiene and Epidemiology, Vietnam
Phase
Phase 2
Overall status
Completed
Start date
June 2, 2017
Completion date
August 12, 2017
Enrollment
220 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

japanese encephalitis